West Pharmaceutical Services, I

Historical 13F Holders

Symbol
WST
CUSIP
955306105
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 774 69.1 M $18.0 B
2025 Q2 753 70.9 M $15.5 B
2025 Q1 739 69.0 M $15.4 B
2024 Q4 775 69.8 M $22.8 B
2024 Q3 768 69.6 M $20.8 B
2024 Q2 816 70.0 M $23.0 B
2024 Q1 816 70.9 M $28.0 B
2023 Q4 820 71.1 M $25.0 B
2023 Q3 793 68.9 M $25.8 B
2023 Q2 761 68.3 M $26.0 B
2023 Q1 723 69.7 M $24.1 B
2022 Q4 663 72.7 M $17.1 B
2022 Q3 663 68.7 M $16.9 B
2022 Q2 680 69.0 M $20.8 B
2022 Q1 750 70.9 M $28.3 B
2021 Q4 762 69.6 M $32.2 B
2021 Q3 700 67.4 M $28.5 B
2021 Q2 673 69.6 M $24.9 B
2021 Q1 612 68.9 M $19.3 B
2020 Q4 616 69.6 M $19.9 B
2020 Q3 594 68.6 M $18.8 B
2020 Q2 546 69.4 M $15.9 B
2020 Q1 491 68.3 M $10.4 B
2019 Q4 459 68.8 M $10.3 B
2019 Q3 434 67.5 M $9.57 B
2019 Q2 408 68.7 M $8.62 B
2019 Q1 399 68.3 M $7.53 B
2018 Q4 370 70.4 M $6.90 B
2018 Q3 372 70.2 M $8.65 B
2018 Q2 334 74.1 M $6.94 B
2018 Q1 329 70.7 M $6.24 B
2017 Q4 344 69.8 M $6.89 B
2017 Q3 308 69.8 M $6.72 B
2017 Q2 315 67.3 M $6.36 B
2017 Q1 301 67.8 M $5.53 B
2016 Q4 295 67.2 M $5.71 B
2016 Q3 284 66.2 M $4.93 B
2016 Q2 292 67.1 M $5.10 B
2016 Q1 257 68.5 M $4.75 B
2015 Q4 256 68.4 M $4.12 B
2015 Q3 254 68.5 M $3.71 B
2015 Q2 221 67.6 M $3.92 B
2015 Q1 216 67.4 M $4.05 B
2014 Q4 230 66.5 M $3.54 B
2014 Q3 220 66.7 M $2.98 B
2014 Q2 229 66.7 M $2.81 B
2014 Q1 229 63.6 M $2.80 B